Mast Cell Tumor Treatment Market

Mast Cell Tumor Treatment Market is forecast to increase from USD 5.80 Billion in 2025 to USD 8.10 Billion by 2036, at a projected CAGR of 3.4%. In terms of drug class, Antihistamines is expected to hold the largest share at 31.5%, while Oral will account for a 62.6% share in the route of administration segment.